COMPANY
Wave Life Sciences
Wave’s oligonucleotides are designed to engage messenger RNA (mRNA) strands inside human cells to repair, restore, or reduce proteins to treat diseases. From company website Source · Oct 12, 2026
Since the raise (Dec 9, 2025): 28 of 28 open jobs were first seen after it.
Hiring
| Title | Location (from posting) | Employer posted | First seen |
|---|---|---|---|
| Senior Director, R&D Quality Assurance | Lexington, MA | Oct 20, 2026 | Oct 21, 2026 |
| Scientist II, Bioanalytical and Biomarker Development | Lexington, MA | Oct 20, 2026 | Oct 21, 2026 |
| Quality Control Co-op (Spring 2027) | Lexington, MA | Oct 16, 2026 | Oct 17, 2026 |
| Biology Co-op (Spring 2027) | USA | Oct 15, 2026 | Oct 16, 2026 |
| Associate Director/Director, Pathology | Lexington, MA | Oct 5, 2026 | Oct 9, 2026 |
Timeline
Open jobs 28
| Title | Location (from posting, not HQ) | Employer posted | First seen | Level |
|---|---|---|---|---|
| Senior Director, R&D Quality Assurance | Lexington, MA | Oct 20, 2026 | Oct 21, 2026 | Not stated |
| Scientist II, Bioanalytical and Biomarker Development | Lexington, MA | Oct 20, 2026 | Oct 21, 2026 | Not stated |
| Quality Control Co-op (Spring 2027) | Lexington, MA | Oct 16, 2026 | Oct 17, 2026 | Not stated |
| Biology Co-op (Spring 2027) | USA | Oct 15, 2026 | Oct 16, 2026 | Not stated |
| Associate Director/Director, Pathology | Lexington, MA | Oct 5, 2026 | Oct 9, 2026 | Senior |
| Formulations, Oligonucleotide Synthesis and Chemistry Co-op (Spring 2027) | Lexington, MA | Sep 30, 2026 | Oct 9, 2026 | Entry |
| Discovery Synthesis & Purification Co-op | Lexington, MA | Sep 30, 2026 | Oct 9, 2026 | Entry |
| Small Scale Synthesis, Oligonucleotide Synthesis and Chemistry Co-op (Spring 2027) | Lexington, MA | Sep 30, 2026 | Oct 9, 2026 | Entry |
| Scientist II/Sr. Scientist I, Process Technology Services, CMC | Lexington, MA | Sep 25, 2026 | Oct 9, 2026 | Mid |
| Legal Associate | Cambridge, Massachusetts, United States | Sep 22, 2026 | Oct 9, 2026 | Mid |
| Process Development Co-op (Spring 2027) | Lexington, MA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| Oligonucleotide Analytical Chemistry Process Development Co-op (Spring 2027) | Lexington, MA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| Oligo Chemistry and Biochemistry Co-op (Spring 2027) | Cambridge, Massachusetts, United States | Sep 17, 2026 | Oct 9, 2026 | Entry |
| Microsoft 365 Copilot AI Co-op (Spring 2027) | Lexington, MA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| IT Systems Administrator Co-op (Spring 2027) | Lexington, MA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| IT Lab and GxP Systems Support Co-op (Spring 2027) | Lexington, MA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| IT ERP and Business Systems Support Co-op (Spring 2027) | USA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| IT Cybersecurity Co-op (Spring 2027) | Lexington, MA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| Intellectual Property/Data Science Co-op (Spring 2027) | USA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| Discovery IT Co-op (Spring 2027) | Cambridge, Massachusetts, United States | Sep 17, 2026 | Oct 9, 2026 | Entry |
| Quality Assurance Co-op (Spring 2027) | USA | Sep 17, 2026 | Oct 9, 2026 | Entry |
| Director, Quality Systems | Lexington, MA | Sep 9, 2026 | Oct 9, 2026 | Senior |
| Buyer II | Lexington, MA | Aug 13, 2026 | Oct 9, 2026 | Mid |
| Senior Business Analyst, Discovery IT | Cambridge, Massachusetts, United States | Aug 13, 2026 | Oct 9, 2026 | Senior |
| Senior IT Business Analyst, GLP & GMP | Lexington, MA | Aug 13, 2026 | Oct 9, 2026 | Senior |
| Senior Manager, End User Service IT | Lexington, MA | Aug 13, 2026 | Oct 9, 2026 | Senior |
| Senior Scientist I, DMPK | Lexington, MA | Aug 13, 2026 | Oct 9, 2026 | Senior |
| Associate Director, Drug Product Technical Services (DPTS) | Lexington, MA | Aug 13, 2026 | Oct 9, 2026 | Senior |
Funding
- Follow-on offering: $350M (total, as published), announced Dec 9, 2025. Source: SEC filing. source ↗